Kabra Drugs - KABRADG, 524322 corporate action history

See all forthcoming Bonus and Splits

See all forthcoming Bonus and Splits

Ex-Date	Purpose	Notes
28 Nov 2025	Others	Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
13 Nov 2025	Quarterly Results	-
08 Oct 2025	Others	Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters.
02 Sep 2025	Others	Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters.
14 Aug 2025	Quarterly Results	-
06 Aug 2025	Others	Inter-alia, to consider 1. To discusses about expansion and new business opportunities. 2. To Broad base the board and to bring in new technical people. 3. Other business matters.
18 Jun 2025	Others	Inter-alia, to consider 1. New acquisition. 2. New drug license for a Chennai office. 3. Diversification by creating new subsidiary. 4. Other business matters.
30 May 2025	Audited Results	-
14 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results	-

See all Rights History for Kabra Drugs